Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of saredutant for the treatment of adaptation, bipolar, and dysthymic disorders

Use of saredutant for the treatment of adaptation, bipolar, and dysthymic disorders

US Patent 6573281 · Granted Jun 3, 2003

Estimated economic value: $321,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof2009
Use of saredutant and of its pharmaceutically acceptable salts for the preparati2008
Use of saredutant and of its pharmaceutically acceptable salts for the preparati2008
Use of saredutant and of its pharmaceutically acceptable salts for the preparati2008
Piperidine derivatives, process for obtaining them and pharmaceutical compositio2005
1-Phenacyl-3-phenyl-3-(piperidylethyl)piperidine derivatives, process for the pr2003
Morpholine derivatives, method for the production thereof and pharmaceutical pre2003
Ureidopiperidine derivatives as selective human NK3 receptor antagonists2002
Osanetant in the treatment of depression and depressive disorders2002
Osanetant in the treatment of depression and depressive disorders2002
Osanetant in the treatment of depression and depressive disorders2002
Use of central cannabinoid receptor antagonists for regulating appetence2002